Epidermolysis Bullosa Clinical Trials

69 clinical trials for Epidermolysis Bullosa across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa — RECRUITING · PHASE3
• A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study — RECRUITING · PHASE2
• Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa — RECRUITING · PHASE1
• Thera-Clean® Microbubbles System in Patients With Skin Diseases — RECRUITING · PHASE1
• Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds — RECRUITING · NA
• A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa — RECRUITING · PHASE3
• Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling — RECRUITING
• Reproductive Options in Inherited Skin Diseases — RECRUITING
• Social Participation of Patients with Epidermolysis Bullosa — RECRUITING
• Changes in the Socio-economic Burden of Epidermolysis Bullosa in Europe — RECRUITING
• Somatic mosaicism in skin fragility disorders: mechanisms and therapeutic perspectives — RECRUITING
• A study of the safety and efficacy of ABH001 in the treatment of patients with epidermolysis bullosa who have wounds that are not healing. — TERMINATED · PHASE3
• Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds — NOT_YET_RECRUITING · PHASE4
• Curcumin-Based Photodynamic Therapy in Epidermolysis Bullosa: Wound Healing, Quality of Life, and Salivary Biomarkers — ACTIVE_NOT_RECRUITING · PHASE4
• A Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of Topically Applied TCP-25 in Patients with Epidermolysis Bullosa — TERMINATED · PHASE2
• Emerging Indications for Hyperbaric Oxygen Treatment — NOT_YET_RECRUITING · PHASE4
• Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) — NOT_YET_RECRUITING · PHASE1
• An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa — NOT_YET_RECRUITING · PHASE3
• Improve Adherence to Weak or Strong Opioid Analgesics at the Time of Care in Children With Hereditary Epidermolysis Bullosa — COMPLETED
• Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa — ACTIVE_NOT_RECRUITING · PHASE1
• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over) — ACTIVE_NOT_RECRUITING · PHASE3
• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa — COMPLETED · NA
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease — SUSPENDED
• A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients — ACTIVE_NOT_RECRUITING · PHASE3
• A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa — WITHDRAWN
• Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution — COMPLETED · PHASE1
• Pregabalin Treatment for RDEB Pain and Itch — COMPLETED · PHASE3
• Oral health of patients with epidermolysis bullosa compared to a healthy control group without - a retrospective study — OTHER
• MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs — COMPLETED · PHASE2
• Study of Cellutome System for Treatment of Individual Lesions in EB Pts — COMPLETED · NA
• Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs — COMPLETED · PHASE1
• Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa. — COMPLETED · PHASE1
• Computational Drug Repurposing for All EBS Cases — OTHER
• Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients — COMPLETED · NA
• Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa — COMPLETED · PHASE1
• Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa — COMPLETED · PHASE3
• A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa — COMPLETED · PHASE2
• Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) — COMPLETED · PHASE3
• Topical Gentamicin Nonsense Suppression Therapy of EB — COMPLETED · PHASE1
• Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. — OTHER · PHASE2
• Reno-urinary involvement in Epidermolysis bullosa patients — NOT_YET_RECRUITING
• The State of Sexual Development in Children With Inherited Epidermolysis Bullosa — OTHER
• Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) — TERMINATED · PHASE1
• The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial — WITHDRAWN · PHASE2
• Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa — WITHDRAWN · PHASE4
• Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex — COMPLETED · PHASE2
• Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa — COMPLETED · PHASE1
• ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa — COMPLETED · PHASE3
• Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients — COMPLETED · PHASE2

Refine this search